<p>亚利桑那州斯科茨代尔，2026 年 5 月 7 日（GLOBE NEWSWIRE）—— LifeStance Health Group, Inc.（“LifeStance” 或 “公司”）（纳斯达克：LFST），是美国最大的虚拟和面对面门诊心理健康护理提供商之一，今天宣布根据向证券交易委员会（“SEC”）提交的货架注册声明，公司的某些股东（“出售股东”）计划提供 35,000,000 股 LifeStance 的普通股，每股面值 0.01 美元（“普通股”）。出售股东将获得此次发行的所有收益。公司在此次发行中不出售任何普通股，也不会从中获得任何收益。</p>
<p>此外，公司已授权在承销商处同时购买 6,000,000 股普通股（“回购”），该回购需在发行完成后进行。公司回购的每股价格将与承销商支付给出售股东的每股价格相同。承销商将不会因公司回购的股份收取任何承销费用。回购需在发行完成后并满足其他惯例条件。此次发行不以回购的完成为条件。</p>
<p>摩根大通担任此次发行的承销商。</p>
<p>LifeStance 于 2024 年 5 月 21 日向 SEC 提交了一份自动货架注册声明（包括招股说明书），该声明在提交时即生效。在您投资之前，您应阅读货架注册声明中的招股说明书及其引用的文件，以及公司向 SEC 提交的招股说明书补充文件，以获取有关公司和此次发行的更完整信息。此次发行仅通过招股说明书及与此次发行相关的招股说明书补充文件进行，副本可通过联系摩根大通证券有限责任公司，地址：1155 Long Island Avenue, Edgewood, NY 11717，或通过电子邮件联系 prospectus-eq_fi@jpmchase.com 和 postsalemanualrequests@broadridge.com 获取。有关此次发行的招股说明书及相关招股说明书补充文件的副本也可以通过访问 SEC 网站的 EDGAR 免费获取，网址为 www.sec.gov。</p>
<p>本新闻稿不构成出售这些证券的要约或购买这些证券的要约邀请，也不应在任何州或司法管辖区内进行这些证券的销售，若该要约、邀请或销售在任何此类州或司法管辖区的证券法下是非法的，除非已进行注册或资格认证。本文件中的任何内容均不应被解释为出售要约或购买与回购相关的任何普通股的要约邀请。</p>
<p><strong>关于 LifeStance</strong></p>
<p>LifeStance 成立于 2017 年（纳斯达克：LFST），正在重新定义心理健康。我们是美国最大的虚拟和面对面门诊心理健康护理提供商之一，服务于经历各种心理健康状况的儿童、青少年和成年人。我们的使命是通过改善人们获得可信、负担得起和个性化的心理健康护理的途径，帮助人们过上更健康、更充实的生活。LifeStance 及其支持的实践机构雇佣了超过 8,300 名精神科医生、高级执业护士、心理学家和治疗师，并在 33 个州和 550 多个中心运营。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿可能包含基于公司信念和假设以及公司当前可获得的信息的 “前瞻性” 声明。前瞻性声明可以通过诸如 “预期”、“相信”、“设想”、“估计”、“期望”、“打算”、“可能”、“计划”、“预测”、“项目”、“目标”、“潜在”、“将”、“会”、“可以”、“应该”、“继续”、“考虑” 等类似表达来识别，尽管并非所有前瞻性声明都包含这些识别词。例如，我们关于拟议公开发行和回购条款的所有声明均为前瞻性声明。</p>
<p>前瞻性声明基于我们对业务、经济和其他未来情况的当前预期和假设。由于前瞻性声明涉及未来，因此本质上存在固有的不确定性、风险和难以预测的情况变化。因此，我们的实际结果可能与任何前瞻性声明所设想的结果存在重大差异。这些风险和不确定性包括但不限于：如果第三方支付者支付的报销率降低，或者第三方支付者以其他方式限制我们获取或提供患者护理的能力，我们的业务可能会受到损害；即使我们的关键指标可能暗示未来增长，我们也可能无法以历史上实现的速度增长，甚至可能根本不增长，包括如果我们无法成功执行我们的增长计划和商业战略；如果我们未能有效管理我们的增长，费用可能会超出预期增加，收入可能不会成比例增加或根本不增加，我们可能无法执行我们的商业战略；我们的增长依赖于我们招聘、获取和留住临床医生的能力；我们在一个竞争激烈的行业中运营，如果我们无法有效竞争，我们的业务、运营结果和财务状况将受到损害；我们的业务依赖于我们有效投资、实施改进和妥善维护信息技术及其他业务系统的持续运营和数据完整性的能力；我们在一个高度监管的行业中开展业务，如果我们未能遵守这些法律和政府法规，可能会遭受处罚或被要求对我们的运营进行重大更改，或经历负面宣传，这可能对我们的业务、运营结果和财务状况产生重大不利影响；我们依赖于与我们不拥有的支持实践的关系来提供医疗服务，如果这些关系受到干扰，或者与这些实体的安排受到法律挑战，我们的业务将受到损害；如果我们无法适应医疗改革立法和医疗行业及医疗支出的其他变化，我们的业务可能会受到损害；如果我们或我们的供应商的安全措施失败或被破坏，未经授权访问我们员工、患者或合作伙伴的数据，我们的系统可能会被视为不安全，我们可能会承担重大责任，包括通过私人诉讼或监管行动，我们的声誉可能会受到损害，我们可能会失去患者和合作伙伴；我们现有的债务可能会对我们的业务和增长前景产生不利影响；以及在我们已提交或将提交给 SEC 的报告中列出的其他风险和不确定性，包括截至 2025 年 12 月 31 日的年度报告（Form 10-K）及后续提交给 SEC 的文件。</p>
<p>基于上述原因，我们提醒您不要依赖任何前瞻性声明，这些声明应与本新闻稿中其他警示性声明和公司在与 SEC 的文件中不时讨论的风险因素一起阅读，这些文件可以在 SEC 网站 http://www.sec.gov 上找到。本次发布中的任何前瞻性声明仅代表本新闻稿发布之日的观点。可能导致我们实际结果不同的因素或事件可能会不时出现，我们无法预测所有这些因素。我们没有义务在本新闻稿发布之日后更新或修订任何前瞻性声明，无论是由于新信息、未来发展还是其他原因，法律要求的情况除外。因此，任何接收者都不应依赖这些前瞻性声明作为公司或其管理层在新闻稿发布之日之后的观点。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RjeE5qQTBOU00zTlRreE5UUXpJekl5TURnNE5ETT0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RjeE5qQTBOU00zTlRreE5UUXpJekl5TURnNE5ETT0"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZjQ0Njk3ZWUtZjcyYy00MzkxLTk3YjgtMjExMGIzYWU2M2I1LTEyMjAzOTYtMjAyNi0wNS0wNy1lbg==/tiny/LifeStance-Health-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZjQ0Njk3ZWUtZjcyYy00MzkxLTk3YjgtMjExMGIzYWU2M2I1LTEyMjAzOTYtMjAyNi0wNS0wNy1lbg==/tiny/LifeStance-Health-Inc-.png"/></p>
<pre><code> 投资者关系联系人：Monica Prokocki，财务与投资者关系副总裁，602-767-2100，investor.relations@lifestance.com
</code></pre>

LFST

美国医疗保健供应商 ETF - iShares

标普全球医疗股指数 ETF - iShares

医疗业 ETF - SPDR

医疗业 ETF - Vanguard

标普医疗保健服务 ETF - SPDR

<p>LifeStance Health Group, Inc. 宣布某些股东将进行 3500 万股普通股的二次公开发行，所得款项将归股东所有。公司不会出售任何股份或获得收益。此外，LifeStance 已授权从承销商摩根大通回购 600 万股，前提是该发行完成。该发行的详细信息已在向美国证券交易委员会（SEC）提交的招股说明书中列出。LifeStance 是美国主要的心理健康护理提供商，在 33 个州雇佣了超过 8300 名专业人员</p>

<p>SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), certain stockholders of the Company (the “Selling Stockholders”) intend to offer 35,000,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.</p>
<div class="lb-trans"><p>亚利桑那州斯科茨代尔，2026 年 5 月 7 日（GLOBE NEWSWIRE）—— LifeStance Health Group, Inc.（“LifeStance” 或 “公司”）（纳斯达克：LFST），是美国最大的虚拟和面对面门诊心理健康护理提供商之一，今天宣布根据向证券交易委员会（“SEC”）提交的货架注册声明，公司的某些股东（“出售股东”）计划提供 35,000,000 股 LifeStance 的普通股，每股面值 0.01 美元（“普通股”）。出售股东将获得此次发行的所有收益。公司在此次发行中不出售任何普通股，也不会从中获得任何收益。</p>
</div><p>In addition, the Company has authorized the concurrent purchase from the underwriter of 6,000,000 shares of Common Stock (the “Repurchase”), subject to the completion of the offering. The price per share for the shares to be repurchased by the Company will be the same as the price per share payable by the underwriter to the Selling Stockholders. The underwriter will not receive any underwriting fees for the shares being repurchased by the Company. The Repurchase will be subject to completion of the offering and the satisfaction of other customary conditions. The offering is not conditioned upon the completion of the Repurchase.</p>
<div class="lb-trans"><p>此外，公司已授权在承销商处同时购买 6,000,000 股普通股（“回购”），该回购需在发行完成后进行。公司回购的每股价格将与承销商支付给出售股东的每股价格相同。承销商将不会因公司回购的股份收取任何承销费用。回购需在发行完成后并满足其他惯例条件。此次发行不以回购的完成为条件。</p>
</div><p>J.P. Morgan is acting as the underwriter for the offering.</p>
<div class="lb-trans"><p>摩根大通担任此次发行的承销商。</p>
</div><p>An automatic shelf registration statement (including a prospectus) relating to the offering of Common Stock was filed by LifeStance with the SEC on May 21, 2024 and became effective upon filing. Before you invest, you should read the prospectus in the shelf registration statement and the documents incorporated by reference therein and the prospectus supplement that the Company has filed with the SEC for more complete information about the Company and the offering. The offering will be made only by means of a prospectus and a related prospectus supplement relating to the offering, copies of which may be obtained by contacting J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at prospectus-eq_fi@jpmchase.com and postsalemanualrequests@broadridge.com. A copy of the prospectus and the related prospectus supplement relating to the offering may also be obtained free of charge by visiting EDGAR on the SEC’s website at www.sec.gov.</p>
<div class="lb-trans"><p>LifeStance 于 2024 年 5 月 21 日向 SEC 提交了一份自动货架注册声明（包括招股说明书），该声明在提交时即生效。在您投资之前，您应阅读货架注册声明中的招股说明书及其引用的文件，以及公司向 SEC 提交的招股说明书补充文件，以获取有关公司和此次发行的更完整信息。此次发行仅通过招股说明书及与此次发行相关的招股说明书补充文件进行，副本可通过联系摩根大通证券有限责任公司，地址：1155 Long Island Avenue, Edgewood, NY 11717，或通过电子邮件联系 prospectus-eq_fi@jpmchase.com 和 postsalemanualrequests@broadridge.com 获取。有关此次发行的招股说明书及相关招股说明书补充文件的副本也可以通过访问 SEC 网站的 EDGAR 免费获取，网址为 www.sec.gov。</p>
</div><p>This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Nothing herein should be construed as an offer to sell, or the solicitation of an offer to buy, any shares of Common Stock subject to the Repurchase.</p>
<div class="lb-trans"><p>本新闻稿不构成出售这些证券的要约或购买这些证券的要约邀请，也不应在任何州或司法管辖区内进行这些证券的销售，若该要约、邀请或销售在任何此类州或司法管辖区的证券法下是非法的，除非已进行注册或资格认证。本文件中的任何内容均不应被解释为出售要约或购买与回购相关的任何普通股的要约邀请。</p>
</div><p><strong>About LifeStance</strong></p>
<div class="lb-trans"><p><strong>关于 LifeStance</strong></p>
</div><p>Founded in 2017, LifeStance (Nasdaq: LFST) is reimagining mental health. We are one of the nation’s largest providers of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Our mission is to help people lead healthier, more fulfilling lives by improving access to trusted, affordable and personalized mental healthcare. LifeStance and its supported practices employ over 8,300 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.</p>
<div class="lb-trans"><p>LifeStance 成立于 2017 年（纳斯达克：LFST），正在重新定义心理健康。我们是美国最大的虚拟和面对面门诊心理健康护理提供商之一，服务于经历各种心理健康状况的儿童、青少年和成年人。我们的使命是通过改善人们获得可信、负担得起和个性化的心理健康护理的途径，帮助人们过上更健康、更充实的生活。LifeStance 及其支持的实践机构雇佣了超过 8,300 名精神科医生、高级执业护士、心理学家和治疗师，并在 33 个州和 550 多个中心运营。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release may contain “forward-looking” statements based on the Company’s beliefs and assumptions and on information currently available to the Company. Forward-looking statements can be identified by words such as “anticipate,” “believe,” “envision,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “potential,” “will,” “would,” “could,” “should,” “continue,” “contemplate” and other similar expressions, although not all forward-looking statements contain these identifying words. For example, all statements we make regarding the terms of the proposed public offering and the Repurchase are forward-looking statements.</p>
<div class="lb-trans"><p>本新闻稿可能包含基于公司信念和假设以及公司当前可获得的信息的 “前瞻性” 声明。前瞻性声明可以通过诸如 “预期”、“相信”、“设想”、“估计”、“期望”、“打算”、“可能”、“计划”、“预测”、“项目”、“目标”、“潜在”、“将”、“会”、“可以”、“应该”、“继续”、“考虑” 等类似表达来识别，尽管并非所有前瞻性声明都包含这些识别词。例如，我们关于拟议公开发行和回购条款的所有声明均为前瞻性声明。</p>
</div><p>Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result, our actual results may differ materially from those contemplated by any forward-looking statements. These risks and uncertainties include, but are not limited to: if reimbursement rates paid by third-party payors are reduced or if third-party payors otherwise restrain our ability to obtain or deliver care to patients, our business could be harmed; we may not grow at the rates we historically have achieved or at all, even if our key metrics may imply future growth, including if we are unable to successfully execute on our growth initiatives and business strategies; if we fail to manage our growth effectively, our expenses could increase more than expected, our revenue may not increase proportionally or at all, and we may be unable to execute on our business strategy; our growth depends on our ability to recruit, acquire and retain clinicians; we operate in a competitive industry, and if we are not able to compete effectively, our business, results of operations and financial condition would be harmed; our business depends on our ability to effectively invest in, implement improvements to and properly maintain the uninterrupted operation and data integrity of our information technology and other business systems; we conduct business in a heavily regulated industry and if we fail to comply with these laws and government regulations, we could incur penalties or be required to make significant changes to our operations or experience adverse publicity, which could have a material adverse effect on our business, results of operations and financial condition; we are dependent on our relationships with supported practices, which we do not own, to provide health care services, and our business would be harmed if those relationships were disrupted or if our arrangements with these entities became subject to legal challenges; if we are unable to adapt to healthcare reform legislation and other changes in the healthcare industry and in healthcare spending, our business could be harmed; if our or our vendors’ security measures fail or are breached and unauthorized access to our employees’, patients’ or partners’ data is obtained, our systems may be perceived as insecure, we may incur significant liabilities, including through private litigation or regulatory action, our reputation may be harmed, and we could lose patients and partners; our existing indebtedness could adversely affect our business and growth prospects; and other risks and uncertainties set forth under “Risk Factors” included in the reports we have filed or will file with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings made with the SEC.</p>
<div class="lb-trans"><p>前瞻性声明基于我们对业务、经济和其他未来情况的当前预期和假设。由于前瞻性声明涉及未来，因此本质上存在固有的不确定性、风险和难以预测的情况变化。因此，我们的实际结果可能与任何前瞻性声明所设想的结果存在重大差异。这些风险和不确定性包括但不限于：如果第三方支付者支付的报销率降低，或者第三方支付者以其他方式限制我们获取或提供患者护理的能力，我们的业务可能会受到损害；即使我们的关键指标可能暗示未来增长，我们也可能无法以历史上实现的速度增长，甚至可能根本不增长，包括如果我们无法成功执行我们的增长计划和商业战略；如果我们未能有效管理我们的增长，费用可能会超出预期增加，收入可能不会成比例增加或根本不增加，我们可能无法执行我们的商业战略；我们的增长依赖于我们招聘、获取和留住临床医生的能力；我们在一个竞争激烈的行业中运营，如果我们无法有效竞争，我们的业务、运营结果和财务状况将受到损害；我们的业务依赖于我们有效投资、实施改进和妥善维护信息技术及其他业务系统的持续运营和数据完整性的能力；我们在一个高度监管的行业中开展业务，如果我们未能遵守这些法律和政府法规，可能会遭受处罚或被要求对我们的运营进行重大更改，或经历负面宣传，这可能对我们的业务、运营结果和财务状况产生重大不利影响；我们依赖于与我们不拥有的支持实践的关系来提供医疗服务，如果这些关系受到干扰，或者与这些实体的安排受到法律挑战，我们的业务将受到损害；如果我们无法适应医疗改革立法和医疗行业及医疗支出的其他变化，我们的业务可能会受到损害；如果我们或我们的供应商的安全措施失败或被破坏，未经授权访问我们员工、患者或合作伙伴的数据，我们的系统可能会被视为不安全，我们可能会承担重大责任，包括通过私人诉讼或监管行动，我们的声誉可能会受到损害，我们可能会失去患者和合作伙伴；我们现有的债务可能会对我们的业务和增长前景产生不利影响；以及在我们已提交或将提交给 SEC 的报告中列出的其他风险和不确定性，包括截至 2025 年 12 月 31 日的年度报告（Form 10-K）及后续提交给 SEC 的文件。</p>
</div><p>For the reasons described above, we caution you against relying on any forward-looking statements, which should be read in conjunction with the other cautionary statements included elsewhere in this press release and risk factors discussed from time to time in the Company’s filings with the SEC, which can be found at the SEC’s website at http://www.sec.gov. Any forward-looking statement in this presentation speaks only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update or revise any forward-looking statement after the date of this press release, whether as a result of new information, future developments or otherwise, except as may be required by law. No recipient should, therefore, rely on these forward-looking statements as representing the views of the Company or its management as of any date subsequent to the date of the press release.</p>
<div class="lb-trans"><p>基于上述原因，我们提醒您不要依赖任何前瞻性声明，这些声明应与本新闻稿中其他警示性声明和公司在与 SEC 的文件中不时讨论的风险因素一起阅读，这些文件可以在 SEC 网站 http://www.sec.gov 上找到。本次发布中的任何前瞻性声明仅代表本新闻稿发布之日的观点。可能导致我们实际结果不同的因素或事件可能会不时出现，我们无法预测所有这些因素。我们没有义务在本新闻稿发布之日后更新或修订任何前瞻性声明，无论是由于新信息、未来发展还是其他原因，法律要求的情况除外。因此，任何接收者都不应依赖这些前瞻性声明作为公司或其管理层在新闻稿发布之日之后的观点。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RjeE5qQTBOU00zTlRreE5UUXpJekl5TURnNE5ETT0" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTcxNjA0NSM3NTkxNTQzIzIyMDg4NDM="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/ZjQ0Njk3ZWUtZjcyYy00MzkxLTk3YjgtMjExMGIzYWU2M2I1LTEyMjAzOTYtMjAyNi0wNS0wNy1lbg==/tiny/LifeStance-Health-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/ZjQ0Njk3ZWUtZjcyYy00MzkxLTk3YjgtMjExMGIzYWU2M2I1LTEyMjAzOTYtMjAyNi0wNS0wNy1lbg==/tiny/LifeStance-Health-Inc-.png"/></p>
<pre><code>Investor Relations ContactMonica ProkockiVP of Finance &amp; Investor Relations602-767-2100investor.relations@lifestance.com
</code></pre>
<div class="lb-trans"><pre><code> 投资者关系联系人：Monica Prokocki，财务与投资者关系副总裁，602-767-2100，investor.relations@lifestance.com
</code></pre>
</div>

LifeStance Health Group 宣布启动二次公开发行 | LFST 股票新闻